News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Digirad Corporation to Release 2011 Third Quarter and Nine-Month Results on November 4, 2011
October 21, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
POWAY, Calif., Oct. 21, 2011 (GLOBE NEWSWIRE) -- October 21, 2011 - Digirad Corporation (Nasdaq:DRAD) will release financial results for its third quarter and nine months ended September 30, 2011, before the market opens on Friday, November 4, 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Earnings
BioMarin Abandons Gene Therapy Roctavian, Cuts Revenue Guidance as Voxzogo Faces Competitors
October 28, 2025
·
4 min read
·
Tristan Manalac
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
October 27, 2025
·
3 min read
·
Annalee Armstrong
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
October 27, 2025
·
2 min read
·
Tristan Manalac
M&A
Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity Acquisition
October 26, 2025
·
2 min read
·
Heather McKenzie